In more heart news, according to DrugInfoNet, more deaths have been linked to theNatrecor Heart Drug, unfortunately. These developments have caused the United States Food and Drug Administration withdraw the drug from the market, the Associated Press reported.
The new fatalities bring to 7 the number of patients who died within thirty days of being treated with Natrecor during the research study, which was conducted some 3 years ago.
New York cardiologist Dr. Jonathon Sackner-Bernstein has stated that he thinks the drug should be withdrawn. He was the lead author of a report that was critical of Natrecor that was published last year in the Journal of the American Medical Association.
The FDA approved Natrecor in the year 2001 to treat serious breathing problems related to heart failure. Early in 2005, the FDA ordered that more information about the risk of death from the drug be included in the package insert for physicians.
The new fatalities bring to 7 the number of patients who died within thirty days of being treated with Natrecor during the research study, which was conducted some 3 years ago.
New York cardiologist Dr. Jonathon Sackner-Bernstein has stated that he thinks the drug should be withdrawn. He was the lead author of a report that was critical of Natrecor that was published last year in the Journal of the American Medical Association.
The FDA approved Natrecor in the year 2001 to treat serious breathing problems related to heart failure. Early in 2005, the FDA ordered that more information about the risk of death from the drug be included in the package insert for physicians.
0 Comments:
Post a Comment
<< Home